Support from New York City's office of chief medical examiner for people bereaved by drug poisoning: development and implementation of the family support program.
Karli R Hochstatter, Hannah Johnson, Megan Brown, Jan Gryczynski, Talia Nadel, Jason Graham
{"title":"Support from New York City's office of chief medical examiner for people bereaved by drug poisoning: development and implementation of the family support program.","authors":"Karli R Hochstatter, Hannah Johnson, Megan Brown, Jan Gryczynski, Talia Nadel, Jason Graham","doi":"10.1186/s12954-026-01482-2","DOIUrl":null,"url":null,"abstract":"<p><p>Bereavement from loss related to drug poisoning, the leading cause of injury-related death in the United States, is associated with elevated risk for prolonged grief disorder, substance use, and poor mental health outcomes. Despite this, few interventions specifically target survivors of overdose loss. The Family Support Program (FSP) is a novel, social worker-delivered bereavement support service provided by the Drug Intelligence and Intervention Group of the New York City Office of Chief Medical Examiner for family, friends, and other close social network members bereaved by drug poisoning. The FSP integrates evidence-based components including motivational interviewing, psychoeducation, social support, and linkage to care to reduce grief-related distress and improve psychosocial functioning. This paper describes the development, implementation, and pilot-phase adaptations of the FSP, including program design, staffing strategies, data infrastructure, and lessons learned. This paper can guide medical examiner and coroner offices in developing responsive, trauma-informed services for individuals affected by drug poisoning loss.</p>","PeriodicalId":12922,"journal":{"name":"Harm Reduction Journal","volume":" ","pages":""},"PeriodicalIF":4.2000,"publicationDate":"2026-06-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13471532/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Harm Reduction Journal","FirstCategoryId":"90","ListUrlMain":"https://doi.org/10.1186/s12954-026-01482-2","RegionNum":2,"RegionCategory":"社会学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"SUBSTANCE ABUSE","Score":null,"Total":0}
引用次数: 0
Abstract
Bereavement from loss related to drug poisoning, the leading cause of injury-related death in the United States, is associated with elevated risk for prolonged grief disorder, substance use, and poor mental health outcomes. Despite this, few interventions specifically target survivors of overdose loss. The Family Support Program (FSP) is a novel, social worker-delivered bereavement support service provided by the Drug Intelligence and Intervention Group of the New York City Office of Chief Medical Examiner for family, friends, and other close social network members bereaved by drug poisoning. The FSP integrates evidence-based components including motivational interviewing, psychoeducation, social support, and linkage to care to reduce grief-related distress and improve psychosocial functioning. This paper describes the development, implementation, and pilot-phase adaptations of the FSP, including program design, staffing strategies, data infrastructure, and lessons learned. This paper can guide medical examiner and coroner offices in developing responsive, trauma-informed services for individuals affected by drug poisoning loss.
期刊介绍:
Harm Reduction Journal is an Open Access, peer-reviewed, online journal whose focus is on the prevalent patterns of psychoactive drug use, the public policies meant to control them, and the search for effective methods of reducing the adverse medical, public health, and social consequences associated with both drugs and drug policies. We define "harm reduction" as "policies and programs which aim to reduce the health, social, and economic costs of legal and illegal psychoactive drug use without necessarily reducing drug consumption". We are especially interested in studies of the evolving patterns of drug use around the world, their implications for the spread of HIV/AIDS and other blood-borne pathogens.